Great West Life Assurance Co. Can purchased a new position in Zuora, Inc. (NYSE:ZUO – Get Rating) during the third quarter, HoldingsChannel reports. The fund purchased 549,808 shares of the company’s stock, valued at approximately $4,063,000.
Other large investors also recently added to or reduced their stakes in the company. Versor Investments LP increased its stake in Zuora by 344.3% in the 2nd quarter. Versor Investments LP now owns 100,604 shares of the company’s stock worth $900,000 after acquiring an additional 77,962 shares during the last quarter. PFS Investments Inc. increased its stake in Zuora by 12.8% in the 2nd quarter. PFS Investments Inc. now owns 91,348 shares of the company’s stock worth $818,000 after acquiring an additional 10,336 shares during the last quarter. Baillie Gifford & Co. increased its stake in Zuora by 4.2% in the 3rd quarter. Baillie Gifford & Co. now owns 4,885,232 shares of the company’s stock worth $36,053,000 after acquiring an additional 197,661 shares during the last quarter. Royce & Associates LP bought a new stake in Zuora in the 2nd quarter worth approximately $194,000. Finally, Kettle Hill Capital Management LLC bought a new stake in Zuora in the 2nd quarter worth approximately $1,871,000. 69.11% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Zuora news, CRO Robert J. Traube sold 30,736 shares of the stock in a transaction on Wednesday, January 18th. The stock was sold at an average price of $7.04, for a total value of $216,381.44. Following the sale, the executive now owns 32,927 shares in the company, valued at $231,806.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, insider Andrew M. Cohen sold 23,348 shares of the firm’s stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $6.32, for a total transaction of $147,559.36. Following the sale, the insider now owns 46,124 shares of the company’s stock, valued at $291,503.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CRO Robert J. Traube sold 30,736 shares of the firm’s stock in a transaction dated Wednesday, January 18th. The shares were sold at an average price of $7.04, for a total value of $216,381.44. Following the sale, the executive now directly owns 32,927 shares in the company, valued at approximately $231,806.08. The disclosure for this sale can be found here. Insiders have sold a total of 137,471 shares of company stock worth $884,089 over the last quarter. Company insiders own 9.08% of the company’s stock.
Wall Street Analysts Forecast Growth
Zuora Trading Up 2.7 %
ZUO stock opened at $6.73 on Monday. The company has a current ratio of 2.24, a quick ratio of 2.24 and a debt-to-equity ratio of 1.13. The business’s fifty day simple moving average is $6.77 and its two-hundred day simple moving average is $7.68. Zuora, Inc. has a twelve month low of $5.45 and a twelve month high of $17.02.
Zuora (NYSE:ZUO – Get Rating) last released its earnings results on Tuesday, December 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.02. Zuora had a negative return on equity of 61.56% and a negative net margin of 32.65%. The business had revenue of $101.07 million for the quarter, compared to analyst estimates of $99.50 million. As a group, analysts predict that Zuora, Inc. will post -0.98 earnings per share for the current year.
Zuora Company Profile
Zuora, Inc, together with its subsidiaries, provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The company offers Zuora Central platform that acts as an orchestration engine that allows customers quote-to-revenue operations.
Featured Stories
- Get a free copy of the StockNews.com research report on Zuora (ZUO)
- CVS Health is Growing into an Integrated Healthcare Organization
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Want to see what other hedge funds are holding ZUO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zuora, Inc. (NYSE:ZUO – Get Rating).
Receive News & Ratings for Zuora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zuora and related companies with MarketBeat.com's FREE daily email newsletter.